Melissa D. Krebs

Melissa D. Krebs

Department of Chemical & Biological Engineering, Colorado School of Mines

Affiliated withColorado School of Mines

Research Area

Biography

Melissa received a B.S. and M.S. in Chemical Engineering from the University of Rochester. She then worked at Charles Stark Draper Laboratory, Inc. in Cambridge, MA, focusing on applications in biodefense and medical diagnostics. She returned to graduate school to pursue a Ph.D. in Biomedical Engineering at Case Western Reserve University in Cleveland, OH in the field of biomaterials and tissue regeneration and was awarded a National Science Foundation Graduate Fellowship to support her work. After graduating with her Ph.D., Melissa was an American Cancer Society Postdoctoral Fellow and Research Assistant Professor in Biomedical Engineering at Case Western Reserve University. She was awarded the TERMIS Wake Forest Institute for Regenerative Medicine Young Investigator Award. She also spent a year as a Visiting Scientist in Cancer Biology at University of Colorado Anschutz Medical Campus. Melissa is now an Associate Professor in Chemical & Biological Engineering at Colorado School of Mines; she joined the department in August 2012. She is also a faculty member in the Charles Gates Center for Regenerative Medicine & Stem Cell Biology and is an Adjoint Associate Professor in Ophthalmology at University of Colorado School of Medicine. She was awarded a Boettcher Foundation Webb-Waring Early Career Investigator, received the Colorado School of Mines Inventor of the Year award in 2017, and in 2020 was awarded the Colorado School of Mines Faculty Excellence Award. Melissa is also CEO and Founder of a startup company GelSana Therapeutics, Inc.

JoVE Journal Publications

ArticleTotal : 2
Year
A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies
Publication title

Cited by 21

2017
2022

Other Publications

Article
Year
Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation.

Biomaterials| PubMed ID: 24831973

2014
Controlled delivery of antibodies from injectable hydrogels.

Materials science & engineering. C, Materials for biological applications| PubMed ID: 26652435

2016
2016
2016
2017
2017
Regenerative Medicine Approaches for the Treatment of Pediatric Physeal Injuries.

Tissue engineering. Part B, Reviews| PubMed ID: 28830302

2018
2017
2019
Imaging and Analysis of Cellular Locations in Three-Dimensional Tissue Models.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada| PubMed ID: 30853032

2019
2020
In vivo degradation rate of alginate-chitosan hydrogels influences tissue repair following physeal injury.

Journal of biomedical materials research. Part B, Applied biomaterials| PubMed ID: 32034881

2020
2020
Anti-VEGF antibody delivered locally reduces bony bar formation following physeal injury in rats.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society| PubMed ID: 33179297

2021
2017
Tunable chitosan-calcium phosphate composites as cell-instructive dental pulp capping agents.

Journal of biomaterials science. Polymer edition| PubMed ID: 33941040

2021
2022
2022